NovoCure's Cash & Current Investments rose 766.78% to $1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year increase of 766.78%. This contributed to the annual value of $959.9 million for FY2024, which is 540.92% up from last year.
As of Q3 2025, NovoCure's Cash & Current Investments stood at $1.0 billion, which was up 766.78% from $911.5 million recorded in Q2 2025.
In the past 5 years, NovoCure's Cash & Current Investments ranged from a high of $1.0 billion in Q3 2025 and a low of $864.4 million during Q1 2021
For the 5-year period, NovoCure's Cash & Current Investments averaged around $936.9 million, with its median value being $937.7 million (2021).
In the last 5 years, NovoCure's Cash & Current Investments soared by 29671.21% in 2021 and then crashed by 917.38% in 2024.
Quarter analysis of 5 years shows NovoCure's Cash & Current Investments stood at $937.7 million in 2021, then increased by 3.38% to $969.4 million in 2022, then fell by 6.07% to $910.6 million in 2023, then increased by 5.41% to $959.9 million in 2024, then grew by 7.67% to $1.0 billion in 2025.
Its last three reported values are $1.0 billion in Q3 2025, $911.5 million for Q2 2025, and $929.1 million during Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value